Construction of a Predictive Model for Neoadjuvant Chemotherapy Response in Advanced High-Grade Serous Ovarian Cancer Based on Tumor-Infiltrating CD19? B Cells: A National Multicenter Retrospective Validation Study

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 78627184b14c7c7d8277ca8509eb26c182e074d2
First added on: Oct 10, 2026